The growing evidence of pharmacogenomics across many clinical applications (oncology, cardiology, pain management) and the value-based care it offers has made its utility palatable across the healthcare industry. However, the lack of policy expansion or access and turnkey technology solutions has restricted adoption and utilization.
Atrium Health has researched and developed an integration model for enterprise wide PGx testing in a community-academic hybrid setting, developed in part with Illumina array technology. The considerations presented will likely guide labs and healthcare organizations with their approach to support PGx integration across service lines and align with system strategic goals and initiatives.
